Recipharm Completes Kemwell Acquisition
PTSM: Pharmaceutical Technology Sourcing and Management
Recipharm’s addition of Kemwell’s Bengaluru, India facility expands its solid- and liquid-dosage capabilities.
Recipharm announced on Feb. 20, 2017 that it completed the acquisition of Kemwell’s pharmaceutical businesses located in Bengaluru, India. The acquisition extends Recipharm’s capabilities in India.
As part of the transaction, Recipharm also has a right of first negotiation to acquire Kemwell’s Indian biopharma business, which is not included in the transaction and will continue to be retained by the sellers.
The acquired business, Recipharm Pharmaservices Private Ltd, employs 1200 and offers development services and commercial manufacturing of solid, semi-solid, liquid, and topical products. The solid-dosage plant was commissioned in 2008 and has approvals from US FDA, European Union, and other regulatory bodies. The oral liquids production plant was commissioned in 2011 and features automated high throughput large volume manufacturing, mainly for the Indian subcontinent. The development business provides formulation development, small-scale manufacturing for clinical trials and analytical services.
The acquisition was announced in April 2016.
Source: Recipharm
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
